Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

scientific article

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1005467155
P356DOI10.1186/S12885-016-2692-4
P3181OpenCitations bibliographic resource ID3973892
P932PMC publication ID4992258
P698PubMed publication ID27542890

P50authorManolis KogevinasQ28320569
Marcela GuevaraQ39700348
Beatriz Pérez-GómezQ40005362
Víctor MorenoQ40183186
Rafael Marcos-GrageraQ43480009
Pilar AmianoQ43521651
Virginia LopeQ45668600
Aurelio BarricarteQ46161972
Ines Gomez-AceboQ50434947
Marina PollanQ51579203
Nuria AragonésQ51631857
Gemma Castaño-VinyalsQ52657955
Adonina TardónQ55454742
Esther Gracia-LavedanQ63790051
M Henar AlonsoQ90228046
Trinidad Dierssen-SotosQ91870814
Rosana Peiro-PerezQ114441113
Maria Jesus Michelena-EchevesteQ114441114
Marian Diaz-SantosQ114735280
P2093author name stringJavier Llorca
Sonia Servitja
Tania Fernandez-Villa
María de Pedro
Andrés Garcia-Palomo
P2860cites workNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisQ24646764
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitorsQ25257303
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancerQ25257496
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health InitiativeQ28165551
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor statusQ28176257
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisitedQ28181502
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancerQ28194496
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyQ28196301
Association of regular aspirin use and breast cancer riskQ28211831
Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohortQ28213690
Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findingsQ28218969
NSAID use and breast cancer risk in the VITAL cohortQ28219138
Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohortQ28219482
Cyclooxygenase-2 and the inflammogenesis of breast cancer.Q30367680
The role of cyclooxygenases in inflammation, cancer, and developmentQ33814331
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyQ33889458
Cyclooxygenase-2: a target for the prevention and treatment of breast cancerQ34277077
Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Q34458235
Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatmentQ35148973
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studiesQ35212665
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.Q36234570
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsQ36498885
Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stageQ36641796
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health StudyQ36678729
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research databaseQ37340253
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancerQ38490106
Medication use and the risk of breast cancerQ39796441
Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cellsQ40228364
Nonsteroidal Anti-inflammatory Drugs and CancerQ40435556
Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breastQ40534891
Nonsteroidal antiinflammatory drugs and breast cancerQ44378169
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort studyQ46743593
Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patientsQ48499081
Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.Q50636879
Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.Q50970275
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.Q53315047
The Relationship of Nonsteroidal Anti-inflammatory Drug Use to the Risk of Breast CancerQ59763658
Breast Cancer and NSAID Use: Heterogeneity of Effect in a Case-Control StudyQ71836037
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitorQ73726017
Nonsteroidal anti-inflammatory drug use and breast cancer riskQ77144771
Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MDQ79852024
Epidemiologic-study of nonsteroidal antiinflammatory drugs and breast-cancerQ84152319
Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer riskQ84773247
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)660
P577publication date2016-08-20
P1433published inBMC CancerQ326300
P1476titleUse of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study
P478volume16